CC2D1A

coiled-coil and C2 domain containing 1A, the group of C2 domain containing

Basic information

Region (hg38): 19:13906201-13930879

Links

ENSG00000132024NCBI:54862OMIM:610055HGNC:30237Uniprot:Q6P1N0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal recessive 3 (Definitive), mode of inheritance: AR
  • intellectual disability, autosomal recessive 3 (Moderate), mode of inheritance: AR
  • autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
  • complex neurodevelopmental disorder (Definitive), mode of inheritance: AR
  • intellectual disability, autosomal recessive 3 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, autosomal recessive 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic16033914; 17149387

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CC2D1A gene.

  • not_provided (471 variants)
  • Inborn_genetic_diseases (264 variants)
  • Intellectual_disability,_autosomal_recessive_3 (66 variants)
  • not_specified (57 variants)
  • CC2D1A-related_disorder (33 variants)
  • Intellectual_disability (5 variants)
  • Ciliopathy (2 variants)
  • Smith-Magenis_Syndrome-like (2 variants)
  • Cerebral_palsy (1 variants)
  • Autosomal_recessive_non-syndromic_intellectual_disability (1 variants)
  • Visual_impairment (1 variants)
  • Global_developmental_delay (1 variants)
  • Premature_ovarian_failure_19 (1 variants)
  • Autism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CC2D1A gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017721.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
170
clinvar
4
clinvar
176
missense
1
clinvar
197
clinvar
60
clinvar
2
clinvar
260
nonsense
7
clinvar
5
clinvar
12
start loss
0
frameshift
16
clinvar
6
clinvar
1
clinvar
23
splice donor/acceptor (+/-2bp)
2
clinvar
23
clinvar
1
clinvar
1
clinvar
27
Total 25 35 201 231 6

Highest pathogenic variant AF is 0.00006478371

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CC2D1Aprotein_codingprotein_codingENST00000318003 2924679
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.008460.9921247390661248050.000264
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9415416060.8920.00004026060
Missense in Polyphen172199.420.862491987
Synonymous0.2122472510.9830.00001701983
Loss of Function4.991555.00.2730.00000286615

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002170.000216
Ashkenazi Jewish0.001920.00169
East Asian0.0004460.000445
Finnish0.000.00
European (Non-Finnish)0.0001960.000194
Middle Eastern0.0004460.000445
South Asian0.0003690.000360
Other0.0005080.000495

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells. The combination of calcium and ATP specifically inactivates the binding with FRE. May play a role in the altered regulation of HTR1A associated with anxiety and major depression. Mediates HDAC-independent repression of HTR1A promoter in neuronal cell. Performs essential function in controlling functional maturation of synapses (By similarity). Plays distinct roles depending on its localization. When cytoplasmic, acts as a scaffold protein in the PI3K/PDK1/AKT pathway. Repressor of HTR1A when nuclear. In the centrosome, regulates spindle pole localization of the cohesin subunit SCC1/RAD21, thereby mediating centriole cohesion during mitosis. {ECO:0000250, ECO:0000269|PubMed:20171170}.;
Disease
DISEASE: Mental retardation, autosomal recessive 3 (MRT3) [MIM:608443]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs. {ECO:0000269|PubMed:16033914}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;EGFR1 (Consensus)

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.719
rvis_EVS
1.45
rvis_percentile_EVS
95.16

Haploinsufficiency Scores

pHI
0.0956
hipred
Y
hipred_score
0.547
ghis
0.478

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.972

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cc2d1a
Phenotype
growth/size/body region phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;positive regulation of I-kappaB kinase/NF-kappaB signaling
Cellular component
fibrillar center;nucleus;microtubule organizing center;cytosol;plasma membrane;membrane;extracellular exosome
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;cadherin binding